The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global surgical robots market size reached US$ 3.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 10.4 Billion by 2027, exhibiting a growth rate (CAGR) of 18% during 2022-2027.
Surgical robots refer to computer-controlled machines that are used for performing minimally invasive (MI) and laparoscopic surgeries. These robots consist of a magnifying high-definition 3-D camera fitted at the tip of the robotic arm that provides an accurate representation of the body parts. They replicate the hand movements of the surgeons and can perform complex procedures using miniaturized surgical instruments that can fit through small incisions. In comparison to traditional surgeries, these robots offer faster recovery time, minimal post-operative discomfort, and reduced risks of infection and scars.
The increasing prevalence of neurological disorders across the globe is one of the key factors driving the growth of the market. In line with this, the rising geriatric population, which is more susceptible to medical ailments, is also contributing to the market growth. Furthermore, the extensive utilization of these robots for performing surgeries, along with the increasing preference for MI procedures by both patients and healthcare providers, is providing a boost to the market growth significantly. For instance, neurosurgical robots are being used for precise positioning of needles in deep intracranial lesions and for retracting delicate neural structures.
Various technological advancements and the integration of the healthcare industry with Artificial Intelligence (AI), Internet of Things (IoT) and virtual and augmented reality (VR/AR) are acting as other growth-inducing factors. Surgical robots are being equipped with 3D imaging systems, HD microscopic cameras, data recorders, motion sensors and robotic controlled catheters that assist surgeons in performing complex procedures accurately. Other factors, including increasing funding and investments for research and development (R&D) in the field of robotics and medical sciences, along with improving healthcare infrastructure across the globe, are also projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global surgical robots market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end-user.
Breakup by Product:
Breakup by Application:
Breakup by End-User:
Breakup by Region:
The global surgical robots market is highly fragmented with the presence of several small and large players competing in terms of price and quality. Some of the major players in the market are:
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Application, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Accuray Incorporated, Auris Health Inc., CMR Surgical, Corindus Vascular Robotics, Intuitive Surgical, Maxar Technologies Limited, Mazor Robotics Ltd., Medrobotics Corporation, Medtronic, Renishaw, Smith & Nephew, SRI International Inc., Stryker Corporation, Think Surgical, Transenterix Inc., Verb Surgical and Zimmer Biomet|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2023-2028
Hyperphosphatemia Drugs Market by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Urology Robotic Surgery Market by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at